drugset / Trial / NCT01015638

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

NCT01015638

Phase 4 Completed 36 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a single-blind (blinded expert grader) study that will enroll 25-30 healthy volunteers without facial acne. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide 5% or clindamycin phosphate and benzoyl peroxide 2.5% and the other side of the face will remain non-treated to serve as a control.

Timeline

Start
2009-08
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzoyl Peroxide Other / unclassified 2.5 % Topical
Comparator Benzoyl Peroxide Other / unclassified 5 % Topical
Comparator Clindamycin Unknown 1 % Topical
Comparator Clindamycin Unknown 1.2 % Topical

Indications